In vitro antileishmanial activity of amphotericin B loaded in poly(epsilon-caprolactone) nanospheres
- PMID: 12683663
- DOI: 10.1080/1061186021000060738
In vitro antileishmanial activity of amphotericin B loaded in poly(epsilon-caprolactone) nanospheres
Abstract
The activity of formulations for amphotericin B (AmB) associated with poly(epsilon-caprolactone) nanospheres and coated with variable amounts of a non ionic surfactant poloxamer 188, was evaluated against AmB-susceptible (WT) and AmB-resistant (AmB(r)) strains of Leishmania donovani amastigotes in thioglycolate-elicited peritoneal macrophages. AmB-nanospheres were more actives than free AmB only against amastigotes of wild strain. The activity was not influenced by the concentration of poloxamer 188 used to stabilize the nanospheres in spite of this surfactant was previously reported to synergy with AmB on the membrane of the resistant parasite. Similarly, this improvement was not mediated through macrophage activation. In fact, these nanoparticle formulations appeared to inhibit both NO and TNF-alpha production induced by the free drug. Therefore, we suggest that the association of AmB with nanospheres may improve the capability of the drug to interact with ergosterol. This hypothesis appears to be supported by the fact that nanospheres did not show any improvement of the AmB activity against the resistant strain (characterized by the absence of ergosterol).
Similar articles
-
The effect of amphotericin b derivatives on Leishmania and immune functions.J Parasitol. 2005 Feb;91(1):158-63. doi: 10.1645/GE-3379. J Parasitol. 2005. PMID: 15856892
-
Toxicity and antileishmanial activity of a new stable lipid suspension of amphotericin B.Antimicrob Agents Chemother. 2003 Dec;47(12):3774-9. doi: 10.1128/AAC.47.12.3774-3779.2003. Antimicrob Agents Chemother. 2003. PMID: 14638481 Free PMC article.
-
Targeted killing of Leishmania donovani in vivo and in vitro with amphotericin B attached to functionalized carbon nanotubes.J Antimicrob Chemother. 2011 Apr;66(4):874-9. doi: 10.1093/jac/dkr002. Epub 2011 Feb 3. J Antimicrob Chemother. 2011. PMID: 21393222 Free PMC article.
-
A novel mechanism for an old drug: amphotericin B in the treatment of visceral leishmaniasis.Biochem Biophys Res Commun. 2011 Dec 9;416(1-2):7-12. doi: 10.1016/j.bbrc.2011.11.023. Epub 2011 Nov 10. Biochem Biophys Res Commun. 2011. PMID: 22100811 Review.
-
Amphotericin-B colloidal dispersion. A review of its use against systemic fungal infections and visceral leishmaniasis.Drugs. 1998 Sep;56(3):365-83. doi: 10.2165/00003495-199856030-00008. Drugs. 1998. PMID: 9777313 Review.
Cited by
-
Lipid Nanocarriers-Enabled Delivery of Antibiotics and Antimicrobial Adjuvants to Overcome Bacterial Biofilms.Pharmaceutics. 2024 Mar 14;16(3):396. doi: 10.3390/pharmaceutics16030396. Pharmaceutics. 2024. PMID: 38543290 Free PMC article. Review.
-
Nanoparticles: New agents toward treatment of leishmaniasis.Parasite Epidemiol Control. 2020 May 23;10:e00156. doi: 10.1016/j.parepi.2020.e00156. eCollection 2020 Aug. Parasite Epidemiol Control. 2020. PMID: 32566773 Free PMC article. Review.
-
Amphotericin B Loaded Polymeric Nanoparticles for Treatment of Leishmania Infections.Nanomaterials (Basel). 2020 Jun 12;10(6):1152. doi: 10.3390/nano10061152. Nanomaterials (Basel). 2020. PMID: 32545473 Free PMC article.
-
Polymeric curcumin nanoparticles by a facile in situ method for macrophage targeted delivery.Bioeng Transl Med. 2018 Nov 5;4(1):141-151. doi: 10.1002/btm2.10112. eCollection 2019 Jan. Bioeng Transl Med. 2018. PMID: 30680325 Free PMC article.
-
Recent Advances in the Development of Antimicrobial Nanoparticles for Combating Resistant Pathogens.Adv Healthc Mater. 2018 Jul;7(13):e1701400. doi: 10.1002/adhm.201701400. Epub 2018 May 2. Adv Healthc Mater. 2018. PMID: 29717819 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
